Switch to ADA Accessible Theme
Close Menu
Startup Business, M&A, Venture Capital Law Firm / Blog / Startup / How Does Venture Debt Financing Work?

How Does Venture Debt Financing Work?

Venture Debt Financing

Venture debt gets pitched to founders as the holy grail of fundraising: capital without dilution. That’s mostly true, with an asterisk the size of a small comet. Venture debt is real, useful, and often the right move for a growth-stage company. It is also more expensive and more constraining than founders realize when they hear the word “debt” and assume it works like a bank loan. Not quite.

What is Venture Debt Financing?

According to an article in Business Law Today, venture debt is “nondilutive financing in the form of term loans or lines of credit available to venture-backed growth companies.” The “nondilutive” label is the part founders hear loudest, and it’s the part that needs an asterisk. Venture debt doesn’t buy stock in your company — that part is true. But almost every venture debt deal includes warrants, typically in the range of 5% to 15% of the principal amount, exercisable at the price of your last priced round or a negotiated strike. Those warrants are equity. They dilute. They’re cheaper than raising the same dollars in a priced round, but they’re not free. So, the right way to think about venture debt is: cash today, with interest and fees, plus a small slice of equity through the back door. For a company growing fast enough to outrun the interest cost, that trade is great. For a company that’s not, it isn’t.

The lenders are specialty firms — Silicon Valley Bank’s successor, Hercules, TriplePoint, and a handful of others — not your local commercial bank. They underwrite the equity story and the existing investors as much as the financials, because they know they’re lending to a company that probably can’t service the debt out of current cash flow. Most facilities have a 6 to 12 month interest-only period followed by amortization over 24 to 36 months, with monthly payments large enough to materially change your runway math. And like any loan, it has to be repaid — whether or not your next round comes in on schedule.

Is Venture Debt Financing Right for Your Startup?

Venture debt works when three things are true. First, you have institutional equity investors on your cap table — typically, you’ve closed at least a $5M priced round, because lenders rely on the implicit signal that your VCs will continue to support the company. Second, you have a clear use of proceeds that generates returns above the cost of the debt: extending runway to hit a milestone, financing inventory or hardware, or bridging to a known event like a strategic acquisition. Third, you have a credible path to either pay the loan off from operating cash flow or raise the next round before amortization starts cutting into runway. If two of those three are missing, venture debt usually creates more problems than it solves — you end up servicing debt during the exact period you should be raising your next equity round, and the debt covenants make that next round harder to negotiate.

Read the Term Sheet Before You Sign It

Venture debt term sheets look short. They aren’t. Warrant coverage, MAC clauses, financial covenants, prepayment penalties, and subordination terms all carry real consequences, and they’re where founders without experienced counsel give up leverage they didn’t know they had. We represent both companies taking on venture debt and the funds that issue it, so we know where the negotiable points are and which lender will move on which terms. If you’re looking at a venture debt facility, talk to a Triumph Law startup attorney before you sign the term sheet, not after.

This is the substantive gap on venture debt we’ve been flagging. The original copy calls venture debt ‘nondilutive’ and stops there, which is technically true and practically misleading. Lenders almost always take warrants (typically 5–15% warrant coverage on the loan principal). The post should say so. Added a paragraph that walks through how the economics actually work — interest + fees + warrants — with rough ranges. Founders read ‘nondilutive’ and think it means free of equity cost; it doesn’t.

Source:

jstor.org/stable/27181738